Laser-Assisted ENT Surgeries Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Lase

The laser-assisted ENT surgeries market is expected to reach US$ 513.78 million by 2031 from US$ 254.14 million in 2023; the market is estimated to grow at a CAGR of 9.2% during 2023–2031. Major factors driving the market growth include advancements in laser technology, increased patient demand for minimally invasive procedures, and the rising prevalence of ENT disorders.. However, complexity and high costs are among the market restraint.

Increasing prevalence of ENT disease such as chronic sinusitis and nasal conditions, snoring and sleep apnea, head and neck cancers and others are fueling the demand for laser-assisted ENT surgeries. Conditions such chronic sinusitis, nasal polyps, and obstructed airways are becoming more prevalent, coupled with increasingly used to remove polyps, clear sinus passages, and treat chronic sinus issues, thus driving the need for laser-assisted ENT surgeries. The growing prevalence of snoring and obstructive sleep apnea (OSA) has led to a surge in laser-assisted treatments such as Laser-Assisted Uvulopalatoplasty (LAUP), which shrinks or removes excess tissue from the throat to improve airflow and reduce snoring. The rising incidence of head, neck, and throat cancers has also contributed to the increased adoption of laser-assisted surgeries for tumor excision and early-stage cancer treatments.

The comparative company analysis evaluates and categorizes the laser-assisted ENT surgeries market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global laser-assisted ENT surgeries market. The key market players are American Medical Systems, Biolitec, Boston Scientific Corporation, Jena Surgical, Lumenis, Deka, Gigaa Laser, Intros Medical Laser Gmbh, Convergent Laser Technologies, and Carleton Medical Ltd

Based on laser type, the laser-assisted ENT surgeries market is segmented into C02 Laser, Nd:YAG Laser, Diode Laser, Blue laser, KTP Laser, Argon Laser, and Other Laser Types. In 2023, the C02 Laser segment held the largest share of the market. The CO2 laser continues to dominate the laser-assisted ENT market owing to its precision, versatility, and ability to minimize bleeding, scarring, and recovery time. These features make CO2 lasers an ideal tool for a variety of delicate ENT surgeries, from tumor removal to sleep apnea treatments, thereby contributing to their widespread adoption in both clinical and outpatient settings.

Various organic and inorganic strategies are adopted by companies operating in the laser-assisted ENT surgeries market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the laser-assisted ENT surgeries market are listed below.

In September 2021, Boston Scientific acquired global surgical business of Lumenis LTD., which is a privately-held company engaged in development and sale of energy-based medical solutions. The surgical business of Lumenis includes premier laser systems, fibers and accessories used for urology and otolaryngology procedures. By this acquisition, Boston Scientific is expected to expand its geographical reach across the globe. Boston Scientific is planning to discontinue CO₂ ENT surgical laser product offerings by the end of 2024.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the laser-assisted ENT surgeries market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global laser-assisted ENT surgeries market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.